Skip to Content
Merck
All Photos(1)

Key Documents

SAB5300197

Sigma-Aldrich

Monoclonal Anti-TGFB1 antibody produced in mouse

clone 4F9C10, ascites fluid

Synonym(s):

CED, DPD1, TGFB, TGFB1, TGFbeta

Sign Into View Organizational & Contract Pricing

Select a Size

100 μL
CHF 473.00

CHF 473.00

Estimated to ship on13 April 2025

All Photos(1)

Select a Size

Change View
100 μL
CHF 473.00

About This Item

UNSPSC Code:
12352203
NACRES:
NA.41

CHF 473.00

Estimated to ship on13 April 2025

biological source

mouse

Quality Level

100

conjugate

unconjugated

antibody form

ascites fluid

antibody product type

primary antibodies

clone

4F9C10, monoclonal

species reactivity

human

technique(s)

direct ELISA: 1:10,000
western blot: 1:500-1:2,000

isotype

IgG2a

shipped in

wet ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... TGF beta1(7040)

Related Categories

Immunogen

Purified recombinant fragment of TGF beta1 expressed in E.coli.
Mouse monoclonal antibody raised against TGF beta1

Physical form

Ascitic fluid containing 0.03% sodium azide.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
PM1207091

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Yu-Cheng Chin et al.
Journal of nanobiotechnology, 20(1), 373-373 (2022-08-12)
The escape of bladder cancer from immunosurveillance causes monotherapy to exhibit poor efficacy; therefore, designing a multifunctional nanoparticle that boosts programmed cell death and immunoactivation has potential as a treatment strategy. Herein, we developed a facile one-pot coprecipitation reaction to

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service